REVIEW
Published on 02 Jul 2026
Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review
doi 10.3389/fonc.2026.1830731
- 487 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Evolving non-invasive biomarkers: Chemokines and multi-omic profiling in NSCLC immunotherapy response
Evolving non-invasive biomarkers: Chemokines and multi-omic profiling in NSCLC immunotherapy response
216
Total downloads
3,549
Total views and downloads
Articles
REVIEW
Published on 08 May 2026
Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review
doi 10.3389/fimmu.2026.1780459
- 1,796 views
- 1 citation
ORIGINAL RESEARCH
Accepted on 02 Jul 2026
ctDNA-Derived Copy-Number Signatures Associated with Immune Checkpoint Inhibitor Resistance Beyond PD-L1 and TMB in Advanced NSCLC
- 118 views
ORIGINAL RESEARCH
Accepted on 06 Jul 2026
Predicting Response to Immune Checkpoint Inhibitor plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma following First-Generation TKI Resistance: A Multicenter Deep Learning Study
MINI REVIEW
Accepted on 06 Jul 2026
Evolving Non-Invasive Biomarkers in NSCLC Immunotherapy: Integrating Liquid Biopsy and Multi-Omics Profiling for Precision Oncology
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Thoracic Oncology
Other participating journals
Frontiers in Immunology
- 7.0 impact factor
- 11.3 citescore